Table 1.
Demographics and baseline characteristics of the total population (n = 42)
| Parameter | Total: 47 eyes of 42 patients |
|---|---|
| Age (years) | |
| Mean ± SD | 78.15 ± 8.55 |
| Range | 54–91 |
| Sex, n (%) | |
| Female | 28 (66.7%) |
| Male | 14 (33.3%) |
| Study eye, n (%) | |
| Right | 20 (42.6) |
| Left | 27 (57.4) |
| Ethnicity, n (%) | |
| White | 41 (97.6%) |
| Asian | 1 (2.4%) |
| Hispanic or Latino | 0 |
| Black/African American | 0 |
| Glaucoma type, n (%) | |
| POAG | 32 (68.1) |
| Pseudoexfoliative | 11 (23.4) |
| Low tension | 4 (8.5) |
| Previous glaucoma procedures | |
| Selective laser trabeculoplasty, n (%) | 20 (42.6) |
| iStent, n (%) | 1 (2.1) |
| Endocyclophotocoagulation, n (%) | 1 (2.1) |
| Filtration or tube surgery, n (%) | 0 |
| IOP at baseline | |
| Mean ± SD | 22.34 (7.34) |
| Range | 11.00–36.00 |
| Mean medications at baseline, n (SD) | 2.96 (1.20) |
| Total number, n (%) | |
| None | 1 (2.1) |
| One | 3 (6.4) |
| Two | 10 (21.3) |
| Three | 22 (46.8) |
| Four | 7 (14.9) |
| Five or more | 4 (8.5) |
| XEN® stent and cataract surgery, n (%) | 27 (57.4) |
| XEN® stent as standalone, n (%) | 20 (42.6) |
| Phakic, n (% of 20) | 7 (35) |
Pseudophakic, n (% of 20) 13 (65)